銷售據點

  

|       

銷售據點
 

重要安全資訊：FreeStyle LibreLink Android 應用程式使用者應儘速將應用程式更新至最新版本2.8.4，避免在使用 Android OS 13 時可能發生訊號持續中斷的情形。

ADC-71378 v1.0 02/23

 

參考文獻

參考文獻：

† 檔案資料。亞培糖尿病照護事業部。

‡ FreeStyle LibreLink 應用程式僅相容於特定的行動裝置及作業系統。使用應用程式前，請查閱我們的相容性指南，詳細瞭解裝置的相容性。

∆ 適用條款及細則。此處可檢查您是否符合條件。

縮寫：HbA1c/A1 = 糖化血色素； BGM = 血糖監測； CGM = 連續葡萄糖監測； HCP = 專業醫護人員； hypo = 低血糖事件； ISF = 組織間液； MDI = 每日多次注射； RCT = 隨機對照試驗； SMBG = 血糖自我監測； TIR = 目標範圍內的時間； T1D = 第一型糖尿病； T2D = 第二型糖尿病。

‡‡ LibreLinkUp 應用程式僅相容於特定的行動裝置和作業系統。使用應用程式前，請查看 www.librelinkup.com 詳細瞭解裝置的相容性。需註冊 LibreView 才能使用 LibreLinkUp 和 FreeStyle LibreLink。LibreLinkUp 行動應用程式不可做為主要的血糖監測方式：居家使用者依據應用程式提供的資訊判讀醫療狀況或調整治療之前，務必參照主要監測裝置並諮詢醫師。

§§ LibreView 網站僅相容於特定作業系統及瀏覽器，詳細資訊請參見 www.libreview.com。

## 需註冊 LibreView 才能使用 FreeStyle LibreLink。自動上傳需要無線網路或行動網路連線。

  1. Ajjan R, et al. Continuous Glucose Monitoring: A Brief Review for Primary Care Practitioners. Adv Ther 2019;36:579-596. https://doi.org/10.1007/s12325-019-0870-x.
  2. Alva S, et al. Accuracy of a 14-Day Factory-Calibrated Continuous Glucose Monitoring System With Advanced Algorithm in Pediatric and Adult Population With Diabetes. J Diabetes Sci Technol 2020. https://doi.org/10.1177/1932296820958754.
  3. Battelino T, et al. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range. Diabetes Care. 2019. https://doi.org/10.2337/dci19-0028.
  4. Beck RW, et al. Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials. Diabetes Care 2019;42(3):400–405. https://doi.org/10.2337/dc18-1444.
  5. Carlson AL, et al. Flash glucose monitoring in type 2 diabetes managed with basal insulin in the USA: a retrospective real-world chart review study and meta-analysis. BMJ Open Diab Res Care. 2022. https://doi.org/10.1136/bmjdrc-2021-002590.
  6. Cengiz E, and Tamborlane WV. A tale of two compartments: interstitial versus blood glucose monitoring. Diabetes Technol Ther. 2009;11 Suppl 1(Suppl1):S11-S16. doi:10.1089/dia.2009.0002.
  7. Charleer S, et al. Quality of Life and Glucose Control After 1 Year of Nationwide Reimbursement of Intermittently Scanned Continuous Glucose Monitoring in Adults Living With Type 1 Diabetes (FUTURE): A Prospective Observational Real-World Cohort Study. Diabetes Care 2020;43(2):389-397. https://doi.org/10.2337/dc19-1610.
  8. Edge J, Acerini C, Campbell F, et al. An alternative sensor-based method for glucose monitoring in children and young people with diabetes. Archives of Disease in Childhood 2017;102:543-549. https://doi.org/10.1136/archdischild-2016-311530.
  9. Fokkert M, et al. Improved well-being and decreased disease burden after 1-year use of flash glucose monitoring (FLARE-NL4). BMJ Open Diabetes Research and Care 2019;7:e000809. doi: 10.1136/bmjdrc-2019-000809.
  10. FreeStyle Libre 2 User Manual (TW).
  11. Garden GL, et al. HbA1c and hypoglycaemia outcomes for people with type 1 diabetes due to the introduction of a single-day structured education programme and flash glucose monitoring. Br J Diabetes 2021;21:84-88. https://doi.org/10.15277/bjd.2021.284
  12. Lang J, et al. Expanded Real-World Use Reaffirms Strong Correlation between Scanning Frequency of Flash Glucose Monitoring and Glucose Control. Diabetes 1 June 2019; 68 (Supplement_1): 972–P. https://doi.org/10.2337/db19-972-P.
  13. Seibold AJ, Minimizing Adverse Skin Reactions to Wearable Continuous Glucose Monitoring Sensors in Patients With Diabetes. J Diabetes Sci Technol. 2021 May;15(3):713-714. doi: 10.1177/1932296820984763.
  14. Unger J, et al. Practical guidance for using the FreeStyle Libre flash continuous glucose monitoring in primary care. Postgrad Med. 2020 May;132(4):305-313. doi: 10.1080/00325481.2020.1744393.
  15. Vigersky RA, et al. The Relationship of Hemoglobin A1C to Time-in-Range in Patients with Diabetes. Diabetes Technol Ther. 2019 Feb;21(2):81-85. doi: 10.1089/dia.2018.0310.
  16. Yaron M, et al. Effect of Flash Glucose Monitoring Technology on Glycemic Control and Treatment Satisfaction in Patients With Type 2 Diabetes. Diabetes Care. 2019 Jul;42(7):1178-1184. doi: 10.2337/dc18-0166.

Cookies政策

FreeStyle Libre會使用cookies來改善您的網站體驗，請確定您同意接受本網站之私隱政策才可繼續瀏覽。

Change country
Taiwan (zh-TW)

FreeStyle Libre 2 瞬感2掃描式葡萄糖監測系統適用於 (4 歲以上) 糖尿病糖友，測量組織間液的葡萄糖狀態。4 – 17 歲的兒童使用 FreeStyle Libre 2系統，僅限由 18 歲以上的照護者負責監督、管理並協助判讀葡萄糖數值。專業醫護人員及消費者應注意，關於本產品應用於需要糖尿病管理的其他糖友群體，現有科學證據仍有其限制。請務必詳閱產品說明書，並依指示使用。

 

Abbott Logo

© 2022 Abbott，FreeStyle、Libre 及相關品牌標誌為亞培之商標 北市衛器廣字第111090114號 ADC‑65719 v1.0 11/22 衛部醫器輸字第034368號

您即將離開亞培旗下的網站，並進入第 3 方網站

任何亞培全球網站以外的連結均不受亞培管制，亞培不會對任何該類網站的內容或來自該類網站的任何連結負責。 亞培向您提供這些網站連結只是為了方便，而該類連結並不意味著亞培認可這些網站。

您即將進入的網站也可能未針對您的屏幕大小作出調整。

您想繼續並退出本網站嗎？